Frontiers in Endocrinology (Nov 2024)
Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III
- Jianhao Huang,
- Jianhao Huang,
- Hongyan Shi,
- Hongyan Shi,
- Muye Song,
- Muye Song,
- Jinan Liang,
- Jinan Liang,
- Zhiyuan Zhang,
- Zhiyuan Zhang,
- Xiaohang Chen,
- Xiaohang Chen,
- Yongchen Liu,
- Sanming Wang,
- Zeyu Wu
Affiliations
- Jianhao Huang
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jianhao Huang
- Shantou University Medical College, Shantou, China
- Hongyan Shi
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Hongyan Shi
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Muye Song
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Muye Song
- School of Medicine, South China University of Technology, Guangzhou, China
- Jinan Liang
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jinan Liang
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Zhiyuan Zhang
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Zhiyuan Zhang
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Xiaohang Chen
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Xiaohang Chen
- Shantou University Medical College, Shantou, China
- Yongchen Liu
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Sanming Wang
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Zeyu Wu
- Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- DOI
- https://doi.org/10.3389/fendo.2024.1517690
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
- thyroid cancer
- autoimmune thyroid antibodies
- tumor size
- fine needle aspirate (FNA)
- microcalcification
